NCT03727126 is a NA clinical trial of Robotic esophagectomy in Esophageal Cancer, sponsored by GEM Hospital & Research Center.

Who is sponsoring NCT03727126?

NCT03727126 is sponsored by GEM Hospital & Research Center.

What drugs are being tested in NCT03727126?

Interventions in NCT03727126: Robotic esophagectomy, Thoracolaparoscopic esophagectomy.

What condition does NCT03727126 study?

NCT03727126 studies Esophageal Cancer.

Is NCT03727126 still recruiting?

NCT03727126 is currently status unknown. Last updated 14 October 2020.

Last reviewed 2020-10-14 · How we verify

NCT03727126

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer

Status unknown NA Last updated 14 October 2020

What this trial tests

NA trial testing Robotic esophagectomy in Esophageal Cancer in 40 participants. Status unknown.

Timeline

1 November 2018

Primary endpoint
31 December 2020

1 January 2021

Quick facts

Lead sponsor	GEM Hospital & Research Center
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	40
Start date	1 November 2018
Primary completion	31 December 2020
Estimated completion	1 January 2021
Sites	2 locations across India

Drugs / interventions tested

Robotic esophagectomy
Thoracolaparoscopic esophagectomy

Conditions studied

Esophageal Cancer — all drugs for Esophageal Cancer →

Sponsor

GEM Hospital & Research Center

Who can join

Eligibility, any sex, with Esophageal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Esophageal cancer is a debilitating condition. The treatment involved is complex requiring a combination of chemotherapy and surgery in most cases. Complete removal of the tumor and the adjacent lymph nodes is of utmost importance in improving the survival. Lymph node yield following surgery helps in proper staging of the disease and is an important prognosticating variable. It is hypothesized that the lymph node yield following robotic esophagectomy is higher than that following thoracolaparoscopic esophagectomy. The study aims to compare the short term oncological outcomes following robotic esophagectomy and thoracolaparoscopic esophagectomy for carcinoma esophagus.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Esophageal Cancer

Currently open trials in the same condition.

NCT07464470 — Comparison of Molecular-Genetic Concordance of the Primary Tumor and Brain Metastases of Gastroesophageal Cancers · recruiting
NCT07431281 — Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Meta · Phase 3 · recruiting
NCT07448493 — Local Treatment Strategies for Brain Metastases of Gastric and Esophageal Cancer · active not recruiting
NCT07410676 — EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors · Phase 1, PHASE2 · recruiting
NCT07307560 — High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients · NA · recruiting

Other GEM Hospital & Research Center trials

Trials by the same sponsor.

NCT04652336 — Study Comparing the Effect of Ligamentum Teres Cardiopexy on de Novo GERD Post LSG · NA · unknown
NCT03563092 — Closed Suction Drain vs no Drain on Symptomatic Seroma Formation After Laparoscopic Inguinal Hernia Repair · NA · completed
NCT03342040 — Transverse Abdominis Plane Block in Laparoscopic Ventral Hernia Repair · NA · completed
NCT03191318 — Comparison of Enhanced Recovery After Surgery (ERAS) Pathway With Conventional Pathway After Laparoscopic Sleeve Gastrec · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03727126 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by GEM Hospital & Research Center
Last refreshed: 14 October 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03727126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing